Blood – a specialized body fluid comprises four components, plasma, red blood cells, white blood cells, and platelets. Blood transports oxygen and nutrients to the lungs and tissues an… Read More
CHICAGO — Patients with transfusion-dependent, low-risk myelodysplastic syndromes (MDS) needed significantly fewer transfusions when treated with luspatercept (Reblozyl) for anemia… Read More
Geron Corporation GERN, a late-stage clinical biopharmaceutical company, today announced that data from the pivotal IMerge Phase 3 clinical trial evaluating the Company’s first-in… Read More
– Acute myeloid leukemia (AML) is one of the most aggressive blood cancers, with a very low survival rate and few options for patients who are ineligible for intensive chemotherapy
&nd… Read More
Results of a Phase III clinical trial conducted by AbbVie for its Bcl-2 inhibitor, venetoclax, show that combining it with azacitidine extends overall survival (OS) in patients with untreate… Read More
AbbVie announced the VIALE-A (M15-656) trial of Venetoclax in combination with azacitidine versus azacitidine in combination with placebo met its dual primary endpoints of statistically sign… Read More
We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies are being developed in an effort to bring imp… Read More